IMS Announces Agreement with European Generic Medicines Association; IMS and EGA Will Work Together to Assess, Support the Growing EU Generic Market.LONDON -- IMS Health IMS Health (NYSE: RX) is an international consulting and data services company that supplies the pharmaceutical industry with sales data and consulting services. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. (NYSE NYSE See: New York Stock Exchange : RX) today announced an exclusive data and knowledge sharing agreement with the European Generic medicines Association (EGA (Enhanced Graphics Adapter) An early IBM video display standard that provided medium-resolution text and graphics. It required a digital RGB Enhanced Color Display or equivalent monitor and was superseded by VGA. EGA - Enhanced Graphics Adapter ) to advance the quality of healthcare decision-making by government and industry stakeholders Stakeholders All parties that have an interest, financial or otherwise, in a firm-stockholders, creditors, bondholders, employees, customers, management, the community, and the government. . Under the agreement, IMS (1) See IP Multimedia Subsystem. (2) (Information Management System) An early IBM hierarchical DBMS for IBM mainframes. IMS was widely implemented throughout the 1970s under MVS and continues to be used under z/OS. will provide the EGA with European generic drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name. sales information from its MIDAS Midas (mī`dəs), in Greek mythology, king of Phrygia. Because he befriended Silenus, the oldest of the satyrs, Dionysus granted him the power to turn everything into gold by touch. database, which tracks 90 percent of prescription drugs in more than 80 countries. In addition, IMS will support the work of the EGA with expert opinion and consultative insights. IMS will be given access to EGA's generic industry information and expertise, supporting and validating the company's development of new offerings for the generic sector. The EGA is the official representative body of the European generic pharmaceuticals industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans. The generic medicines industry is stimulating competitiveness and innovation in the pharmaceutical sector. The organization represents more than 500 companies and their subsidiaries throughout Europe. "This new collaboration will help IMS better serve our generic clients in Europe with innovative offerings, and give the EGA access to third-party, independent data and advice needed to support its critical consultative role in European healthcare policy-making pol·i·cy·mak·ing or pol·i·cy-mak·ing n. High-level development of policy, especially official government policy. adj. Of, relating to, or involving the making of high-level policy: ," said Gilles Pajot, president, IMS European Region. "The result will be greater access to accurate, standardized and timely generics information, which will strengthen working relationships among all generic stakeholders." As part of the agreement, the two organizations will work together to ensure that IMS's standard classifications of generic products remain optimal and relevant to the pharmaceutical industry. "This agreement with IMS will enhance our ability to play an effective part in the European healthcare policy decision-making process and underline the great importance of generic medicines," said Greg Perry, Director General of the EGA. "We continue to work closely with European national governments and EU institutions to develop affordable solutions for pharmaceutical care, and IMS's insights and data will help us strengthen Europe's competitive position within the global pharmaceutical medicines market." About IMS Operating in more than 100 countries, IMS Health is the world's leading provider of information solutions to the pharmaceutical and healthcare industries. With $1.4 billion in 2003 revenue and 50 years of industry experience, IMS offers leading-edge business intelligence products and services that are integral to clients' day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and over-the-counter offerings; and consulting and services solutions that improve ROI (Return On Investment) The monetary benefits derived from having spent money on developing or revising a system. In the IT world, there are more ways to compute ROI than Carter has liver pills (and for those of you who never heard of that expression, it means a lot). and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion